JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
JW (Cayman) Therapeutics Co. Ltd. has appointed Mr. Peng Kuan Chan as a new independent non-executive Director, effective August 28, 2024. With over 30 years of experience in finance and banking, Mr. Chan brings a wealth of knowledge to the board, having held multiple directorships and senior roles in various listed companies. His appointment is part of a broader change in the composition of the company’s board committees.
For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.